Those of us that bought in early 2017, and have added are probably below .50 cost per share. I started at about 2.70 and now around .345. Not much I can do at this point in time. My investment is around $105,000.00 and I own 300,000 shares.

I do not expect much from the company this year but believe if USA changes drug status the entire industry will receive a huge lift and those companies that are taking a serious approach will get the best lift.